Rapid Micro Biosystems, Inc. is a life sciences technology company that provides automation solutions for manufacturing and releasing healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system modernizes and automates outdated microbial quality control testing workflows in pharmaceutical manufacturing. The system supports four applications: Environmental Monitoring for the manufacturing environment, Water for purified water in drug production, In-Process Bioburden for raw materials and in-process products, and Sterility Release for final product testing before release. The RPID stock yearly return is shown above.
The yearly return on the RPID stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2024 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RPID annual return calculation with any dividends reinvested as applicable (on ex-dates).
|